Antiretroviral therapy
著者
書誌事項
Antiretroviral therapy
ASM Press, c2001
大学図書館所蔵 全1件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographies and index
内容説明・目次
内容説明
Authoritative chapters by American and European investigators review new approaches to therapy based on fundamental discoveries on retrovirus infection and reproduction cycle. The volume also covers new approaches to therapy such as the determination of viral load, resistance problems, and the outlook for future advances in antiretroviral therapy.
目次
1. Kinetics of Human Immunodeficiency Virus Type 1 Replication and Therapy (Bharat Ramratnam and Martin H. Markowitz) 2. Cellular Receptors as Targets for Anti-Human Immunodeficiency Virus Agents (Dominique Schols and Erik De Clercq) 3. Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (J. Balzarini and Erik De Clercq) 4. Nonnucleoside Reverse Transcriptase Inhibitors (J. Balzarini, R. Esnouf, and Erik De Clercq) 5. Human Immunodeficiency Virus Type 1 Integrase-Targeted Inhibitor Design (Nouri Neamate, Christophe Marchand, Heather E. Winslow, and Yves Pommier) 6. Inhibitors of Transcription and Transactivation and Anti-Human Immunodeficiency Virus Agents (Jonathan Karn) 7. Oligonucleotides as Antiretroviral Agents (A. Kirk Field) 8. Protease Inhibitors as Anti-Human Immunodeficiency Virus Agents (Dale J. Kempf, Akhteruzzaman Molla, and Ann Hsu) 9. Glycoprotein Processing Enzymes as a Target for Human Immunodeficiency Virus Chemotherapy (A. Stanley Tyms) 10. Cellular Factors as Targets for Anti-Human Immunodeficiency Virus Therapy (Masanori Baba) 11. Therapeutic Human Immunodeficiency Virus Vaccines: Concept (Current Status, and Future Directions, John S. Lambert, Robert R. Redfield, and Edmund C. Tramont) 12. Clinical Usefulness of Human Immunodeficiency Virus Drug Resistance Monitoring (Anne-Mieke Vandamme and Erik De Clercq) 13. Emergence of Drug-Resistant Human Immunodeficiency Virus Type 1 (HIV-1) Variants and their Impact on Antiretroviral Therapy of HIV-1 Infection (Mark F. Kavlick and Hiroaki Mitsuya) 14. Combination Antiretroviral Therapy (Cecile Tremblay, Joan C. Kaplan, and Martin S. Hirsch) 15. Drug-Drug Interactions in Human Immunodeficiency Virus Infections (Charles W. Flexner and Stephen C. Piscitelli)
「Nielsen BookData」 より